Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 45501-45550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05399537
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
PHASE3Recruiting
40 participants
Started: Jul 12, 2024 · Completed: Dec 31, 2026
3 conditions2 sponsors13 locations
NCT06868966
Implications of Myelin in Executive Control in Adolescence and Early Adulthood
N/ARecruiting
128 participants
Started: Jul 12, 2024 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06111794
The REACH Intervention for Caregivers of Veterans and Service Members With TBI
NARecruiting
160 participants
Started: Jul 12, 2024 · Completed: Aug 31, 2026
2 conditions5 sponsors1 location
NCT06371040
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
PHASE1Recruiting
9 participants
Started: Jul 12, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06532708
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
NARecruiting
12 participants
Started: Jul 12, 2024 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT06454357
A Clinical Study of B007 in the Treatment of Pemphigus.
PHASE2/PHASE3Recruiting
132 participants
Started: Jul 12, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors12 locations
NCT06495788
Effect of High-intensity Laser Therapy on Patients With Myogenic Temporomandibular Joint Dysfunction
NANot yet recruiting
40 participants
Started: Jul 12, 2024 · Completed: Dec 20, 2024
1 condition1 sponsor0 locations
NCT06463561
CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea
PHASE4Recruiting
220 participants
Started: Jul 12, 2024 · Completed: Jan 31, 2028
3 conditions2 sponsors1 location
NCT06420596
The Effectiveness of Remote App-assisted Physiotherapy in Patients With Non-specific Low Back Pain (RemotePT)
NAActive, not recruiting
60 participants
Started: Jul 12, 2024 · Completed: Jun 19, 2025
1 condition1 sponsor1 location
NCT06491615
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
N/ARecruiting
1,000 participants
Started: Jul 12, 2024 · Completed: Jun 27, 2054
7 conditions1 sponsor2 locations
NCT06191094
Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy
PHASE4Enrolling by invitation
100 participants
Started: Jul 12, 2024 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT07045662
Health Literacy in Patients With Type 2 Diabetes Mellitus.
NAActive, not recruiting
88 participants
Started: Jul 12, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06517511
Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)
PHASE2Recruiting
42 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2028
1 condition2 sponsors2 locations
NCT06383767
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
PHASE3Recruiting
378 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06386887
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
NARecruiting
20 participants
Started: Jul 11, 2024 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT06264700
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
NARecruiting
60 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2025
1 condition5 sponsors3 locations
NCT06462417
Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis
NARecruiting
15 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT06277037
Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
N/ARecruiting
50 participants
Started: Jul 11, 2024 · Completed: Oct 30, 2029
1 condition1 sponsor18 locations
NCT06455254
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
PHASE2Recruiting
44 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT06434610
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
PHASE2Recruiting
90 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors17 locations
NCT06229873
Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure
PHASE1Recruiting
96 participants
Started: Jul 11, 2024 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06983119
Case-Finding for Neurocognitive Disorders in Pavia
NARecruiting
490 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06334822
Randomised Controlled Trial for Assessing the Effectiveness of an Inclusive Heart Failure Monitoring and TRACKing Solution in the UK.
NARecruiting
270 participants
Started: Jul 11, 2024 · Completed: Jul 30, 2025
1 condition1 sponsor9 locations
NCT06264180
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
PHASE3Recruiting
400 participants
Started: Jul 11, 2024 · Completed: Aug 31, 2034
1 condition1 sponsor49 locations
NCT05866562
Dupilumab in the Treatment of Pediatric Alopecia Areata
PHASE2Recruiting
76 participants
Started: Jul 11, 2024 · Completed: May 30, 2029
1 condition1 sponsor4 locations
NCT06392906
Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)
PHASE3Recruiting
68 participants
Started: Jul 11, 2024 · Completed: Oct 31, 2028
1 condition2 sponsors1 location
NCT06506110
PASS Pain After Surgery
N/AActive, not recruiting
7,000 participants
Started: Jul 11, 2024 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT06577844
Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients
NARecruiting
226 participants
Started: Jul 11, 2024 · Completed: Apr 11, 2026
1 condition1 sponsor1 location
NCT06482190
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers
PHASE1Recruiting
72 participants
Started: Jul 11, 2024 · Completed: Feb 10, 2025
2 conditions2 sponsors3 locations
NCT06362733
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
NARecruiting
44 participants
Started: Jul 11, 2024 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT06263998
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
PHASE1Recruiting
60 participants
Started: Jul 11, 2024 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT06139016
Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
NAEnrolling by invitation
10 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06772701
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
NARecruiting
1,000 participants
Started: Jul 11, 2024 · Completed: Sep 12, 2025
1 condition1 sponsor2 locations
NCT06342986
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
PHASE1Recruiting
33 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2027
4 conditions2 sponsors1 location
NCT06465914
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
PHASE3Active, not recruiting
9,000 participants
Started: Jul 11, 2024 · Completed: Jul 30, 2030
10 conditions1 sponsor5 locations
NCT06420167
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
PHASE2Recruiting
20 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06164678
Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users
NAActive, not recruiting
180 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06380517
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
PHASE3Recruiting
238 participants
Started: Jul 11, 2024 · Completed: May 1, 2027
1 condition3 sponsors70 locations
NCT06481943
A Prospective Research Investigation of Ischemia Using MCG
N/ARecruiting
150 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2026
1 condition3 sponsors2 locations
NCT06439888
Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
PHASE1/PHASE2Recruiting
58 participants
Started: Jul 11, 2024 · Completed: Jan 31, 2027
2 conditions1 sponsor2 locations
NCT06212076
Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients
PHASE1/PHASE2Recruiting
60 participants
Started: Jul 11, 2024 · Completed: Jul 9, 2027
1 condition1 sponsor2 locations
NCT06756802
Reproductive Health in Breast Cancer Survivor
N/AActive, not recruiting
22,000 participants
Started: Jul 11, 2024 · Completed: Jul 11, 2029
1 condition2 sponsors4 locations
NCT06515275
Video-Supported Medication Education for Women Undergoing In Vitro Fertilization (IVF): Quality of Life and Psychosocial Effects
NARecruiting
60 participants
Started: Jul 11, 2024 · Completed: Jul 15, 2025
5 conditions1 sponsor1 location
NCT06889896
Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease
N/AEnrolling by invitation
400 participants
Started: Jul 11, 2024 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06340685
Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency
PHASE1Recruiting
6 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06445023
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
PHASE3Recruiting
915 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor230 locations
NCT06187077
Techquity by FAITH!
NARecruiting
200 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2026
2 conditions4 sponsors1 location
NCT06499883
Agile Development of Innovative, Interactive Hazard Recognition and Mitigation Tools/Learning E-platforms for Workers Involved in Disaster Rescue and Recovery
NANot yet recruiting
64 participants
Started: Jul 11, 2024 · Completed: Jul 12, 2024
1 condition2 sponsors1 location
NCT06287229
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
PHASE1/PHASE2Recruiting
40 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT06379724
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
PHASE4Recruiting
62 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location